CIK 0001484612
- Accelerated filer
- Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 200514392
- Phone
- +1 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $28,997
- in 2 filings
Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-12 | Williamson Steven S. Chief Commercial Officer | Grant or award | +112,000 | 217,939 | ||
| 2024-01-12 | Williamson Steven S. Chief Commercial Officer | Grant or award | +100,000 | 317,939 | ||
| 2024-01-12 | Williamson Steven S. Chief Commercial Officer | Grant or award | +5,904 | 323,843 | ||
| 2024-01-12 | Trigg Leslie Chair and CEO | Grant or award | +212,500 | 601,599 | ||
| 2024-01-12 | Trigg Leslie Chair and CEO | Grant or award | +200,000 | 801,599 | ||
| 2024-01-12 | Trigg Leslie Chair and CEO | Grant or award | +44,938 | 846,537 | ||
| 2024-01-12 | Racine Jean-Olivier Chief Technology Officer | Grant or award | +96,000 | 169,781 | ||
| 2024-01-12 | Racine Jean-Olivier Chief Technology Officer | Grant or award | +100,000 | 269,781 | ||
| 2024-01-12 | Racine Jean-Olivier Chief Technology Officer | Grant or award | +4,638 | 274,419 | ||
| 2024-01-12 | Porter Stacey L. Chief People Officer | Grant or award | +3,586 | 62,216 | ||
| 2024-01-12 | Nash Marc SVP Operations and R&D | Grant or award | +96,000 | 141,233 | ||
| 2024-01-12 | Nash Marc SVP Operations and R&D | Grant or award | +100,000 | 241,233 | ||
| 2024-01-12 | Nash Marc SVP Operations and R&D | Grant or award | +3,162 | 244,395 | ||
| 2024-01-12 | Brottem John L. General Counsel | Grant or award | +96,000 | 144,807 | ||
| 2024-01-12 | Brottem John L. General Counsel | Grant or award | +100,000 | 244,807 | ||
| 2024-01-12 | Brottem John L. General Counsel | Grant or award | +5,060 | 249,867 | ||
| 2024-01-12 | Ahmed Nabeel Chief Financial Officer | Grant or award | +136,000 | 212,819 | ||
| 2024-01-12 | Ahmed Nabeel Chief Financial Officer | Grant or award | +100,000 | 312,819 | ||
| 2024-01-12 | Ahmed Nabeel Chief Financial Officer | Grant or award | +5,904 | 318,723 | ||
| 2024-01-08 | Williamson Steven S. Chief Commercial Officer | Sale | −7,055 | $5.49 | $39K | 105,939 |
Page 9 of 18 · 343 trades